ENST00000403999.7:c.*644A>G
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The ENST00000403999.7(NF2):c.*644A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000763 in 1,073,498 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
ENST00000403999.7 3_prime_UTR
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NF2 | NM_000268.4 | c.1737+2098A>G | intron_variant | Intron 15 of 15 | ENST00000338641.10 | NP_000259.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000539 AC: 82AN: 152190Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.000800 AC: 737AN: 921190Hom.: 1 Cov.: 31 AF XY: 0.000773 AC XY: 329AN XY: 425864
GnomAD4 genome AF: 0.000538 AC: 82AN: 152308Hom.: 0 Cov.: 32 AF XY: 0.000537 AC XY: 40AN XY: 74484
ClinVar
Submissions by phenotype
NF2-related disorder Uncertain:1
The NF2 c.1737+2098A>G variant is predicted to interfere with splicing. To our knowledge, this variant has not been reported in individuals with NF2-related disorders in the literature. This variant is reported in 0.12% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/22-30079688-A-G?dataset=gnomad_r2_1). This variant is classified as a variant of uncertain significance in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/135570/). In an alternate transcript (NM_181831.2) this variant is located in the canonical splice site of the terminal non-coding exon (c.*10-2A>G) and is predicted to disrupt normal splicing (Alamut Visual v2.11). The clinical significance of the NM_181831.2 transcript is currently unknown. However, the consequence of this is not known, and the use of computer prediction programs is not equivalent to functional evidence. Although we suspect this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Neurofibromatosis, type 2 Uncertain:1
- -
not provided Benign:1
NF2: BS1 -
not specified Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at